The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback